ZCM
MD icon

Zebra Capital Management’s Pediatrix Medical MD Stock Holding History

Zebra Capital Management’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,912
Closed -$269K – 501
2019
Q1 		$269K Buy
+9,912
New +$332K 0.14% 305

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PCP
P2 Capital Partners New York $210M AUM 1.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Zebra Capital Management's MD Position: Q2 2019 in Review

Zebra Capital Management sold out of Pediatrix Medical (MD) in Q2 2019, closing a stake of 9,912 shares — an estimated $269K sold.

Zebra Capital Management first reported a position in MD in Q1 2019 and held it in 1 quarter. The position peaked at $269K in Q1 2019. 247 funds tracked by Wall St. Rank hold MD as of Q2 2019.

  • Zebra Capital Management reported no remaining Pediatrix Medical position as of Q2 2019 after selling out during the quarter.
  • Zebra Capital Management sold 9,912 Pediatrix Medical shares in Q2 2019, an estimated $269K.
  • Zebra Capital Management first reported a position in Pediatrix Medical in Q1 2019 and held it in 1 quarter.
  • Zebra Capital Management's Pediatrix Medical position peaked at $269K in Q1 2019.
  • 247 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2019.

Based on Zebra Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.